Project Grant K01AG090118
Award Date
8/16/24
Completion Date
5/31/28
Dollars Obligated
$125K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $1,550,462 to support a 5-year cross-sectional, longitudinal, and observational study investigating the impact of Alzheimer's disease (AD) risk genes, with a focus on APOE E4, on brain function in older Black/African American individuals living with HIV. The project aims to enroll 120 participants with HIV (60 with and 60 without the APOE E4 allele) and 80 demographically...
This Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), supports a comprehensive study to determine the prevalence and clinical characteristics of mild cognitive impairment (MCI) and Alzheimer's-related dementia (ADRD) among older adults living with HIV in Uganda. The $1,103,953 award, which began on Sep 15, 2024 and runs through Aug 31, 2025, will fund the following key activities: Comprehensive neuropsychological assessments among 600 older...
This $407,000 Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by the University of Texas Rio Grande Valley (UTRGV) to investigate the relationship between HIV infection and the onset and progression of Alzheimer's disease (AD) using AD mouse models infected with a chimeric HIV strain. The central hypothesis is that HIV may accelerate the development of cognitive decline in AD. The 2-year study will conduct longitudinal behavioral,...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) will provide $880,000 to Old Dominion University from September 2024 through August 2026. The project aims to investigate the therapeutic effects of microglia depletion and repopulation (MGDR) on mitigating hand and neuropsychiatric symptoms in the context of chronic HIV infection. Specifically, the research will explore the impact of MGDR on brain pathology in HIV-infected mouse models, examining its...
This Project Grant award of $222,000.00 from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) federal grant program, will fund research to investigate whether increasing autophagy via inhibition of the Beclin1-Bcl2 complex can delay age-related phenotypes and improve cognitive decline associated with HIV infection in adult and old mice. The research will be conducted by Florida International University (FIU) from September 30, 2024 to July 31, 2026. The key...
The National Institute on Aging (NIA), through its Aging Research program (CFDA 93.866), has awarded a $534,644.00 Project Grant to Temple University - Of The Commonwealth System Of Higher Education. The grant aims to characterize how the HIV-1 virus decreases neuronal clearance, leading to the progression of HIV-associated neurocognitive disorders like motor dysfunction. Key research activities include determining the post-translational regulation of the SNAPIN protein and its impact on...
This Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,645,585 to the University of Florida to develop an "Intelligent Social Risk Management in AD/ADRD Patients" (ISMART) platform. The goal is to leverage electronic health records and machine learning to identify social determinants of health that impact care and outcomes for people living with dementia, especially those from racial/ethnic minority and socioeconomically disadvantaged...
This $4,950,026 project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The Icahn School of Medicine at Mount Sinai is investigating potential synergy between HIV infection and amyloid beta, a hallmark of Alzheimer's disease, in promoting memory impairment. Researchers will characterize enhanced HIV neuropathogenesis in familial and late-onset Alzheimer's disease mouse models...
This $383,750 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research by the University of Nebraska Medical Center (UNMC) to explore the molecular, neuro-immune and behavioral changes that occur during HIV-associated progressive aging using a long-term humanized mouse model. The goal is to determine how HIV latency and antiretroviral therapy (ART) contribute to premature aging, referred to as "LAAGING", and the associated...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $1,161,154 to the University of South Carolina to conduct research aimed at addressing HIV-1-associated neurocognitive disorders (HAND) in older adults. The key objectives are to: 1) Develop "dendritic spine-targeted" therapeutics, such as the isoflavandiol estrogen S-equol and a specific estrogen B-receptor agonist, to restore synaptodendritic integrity and mitigate neurocognitive...